Does Rallies show Form 4 insider transactions for BLLN?

Yes. Rallies tracks BLLN insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.

Is BLLN research on Rallies investment advice?

No. Rallies provides research, data, and educational context for BLLN. It does not provide personalized investment advice.

BLLN (BillionToOne, Inc. Class A Common Stock) Stock Analysis - Insider Trades

BillionToOne, Inc. Class A Common Stock (BLLN) is a publicly traded the market company. As of May 21, 2026, BLLN trades at $85.01 with a market cap of $3.96B and a P/E ratio of 87.13. BLLN moved +1.24% today. Year to date, BLLN is -12.23%; over the trailing twelve months it is flat. Its 52-week range spans $61.96 to $138.70. Analyst consensus is strong buy with an average price target of $123.33. Rallies surfaces BLLN's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who is trading BLLN stock inside the company?

Recent BLLN insider activity includes Lynch Thomas P. bought 100, Tsao David bought 1.00K, ten Bosch John Roderick bought 800, Johnson Nancy JoAnn bought 6.90K, and Rai Akshay bought 2.50K. Rallies tracks insider transaction dates, shares, prices, and estimated values.

BLLN Key Metrics

Key financial metrics for BLLN
Metric	Value
Price	$85.01
Market Cap	$3.96B
P/E Ratio	87.13
EPS	$0.96
Dividend Yield	0.00%
52-Week High	$138.70
52-Week Low	$61.96
Volume	2
Avg Volume	0
Revenue (TTM)	$354.54M
Net Income	$29.41M
Gross Margin	70.40%

Recent BLLN Insider Trades

Lynch Thomas P. bought 100 (~$6.00K) on Nov 7, 2025.
Tsao David bought 1.00K (~$60.00K) on Nov 7, 2025.
ten Bosch John Roderick bought 800 (~$48.00K) on Nov 7, 2025.
Johnson Nancy JoAnn bought 6.90K (~$414.00K) on Nov 7, 2025.
Rai Akshay bought 2.50K (~$150.00K) on Nov 7, 2025.

Latest BLLN News

BillionToOne Posts 84% Q1 Revenue Surge to $108.4M and Lifts 2026 Guidance — May 6, 2026
BillionToOne Launches Unity Confirm With 100% Diagnostic Concordance — May 1, 2026
BillionToOne Appoints Dr. Allen Chen to Lead Northstar Oncology, Palmer Becomes Emeritus — Apr 2, 2026
BillionToOne Reports 117% Revenue Growth to $83.5M and 15% Market Share — Mar 6, 2026
BillionToOne Q4 Revenue Jumps 113% to $96.1M, Raises 2026 Guidance — Mar 5, 2026

BLLN Analyst Consensus

7 analysts cover BLLN: 0 strong buy, 6 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $123.33.

Common questions about BLLN

Who is trading BLLN stock inside the company?: Recent BLLN insider activity includes Lynch Thomas P. bought 100, Tsao David bought 1.00K, ten Bosch John Roderick bought 800, Johnson Nancy JoAnn bought 6.90K, and Rai Akshay bought 2.50K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
Does Rallies show Form 4 insider transactions for BLLN?: Yes. Rallies tracks BLLN insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is BLLN research on Rallies investment advice?: No. Rallies provides research, data, and educational context for BLLN. It does not provide personalized investment advice.